Reduced Risk of Heart and Brain Blood Vessel Problems with Semaglutide Compared to Tirzepatide

Funding support and author disclosures Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number U54 GM104942. Dr Yedavalli is a consultant for iSchemaView, RapidAI. Dr Altschul reports securities holdings in Von Vascular, Inc, and compensation from Johnson and Johnson International, Stryker Corporation, Medtronic USA, Inc, and MicroVention, Inc, for consultant services. Dr Lakhani is consultant for iSchemaView and RapidAI; scientific advisory board member for Upstream Vision; deputy editor for Radiology: Images in Radiology; and associate editor for Frontiers in Radiology. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.